CAPROCK Group, Inc.
- SEC CIK
- 0001610769
- Latest filing
- Jul 27, 2026
REGN holding history
Regeneron Pharmaceuticals, Inc. in every 13F filed by CAPROCK Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
REGN overviewAll 13F holders of REGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 2,437
- Value
- $1.52M
- % of portfolio
- <0.1%
- Quarters held
- 20
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 2,437 | $1.52M | <0.1% | −331−12.0% | Reduced | Holders |
| Q1 2026 | 2,768 | $2.14M | 0.1% | −133−4.6% | Reduced | Holders |
| Q4 2025 | 2,901 | $2.24M | <0.1% | +373+14.8% | Added | Holders |
| Q3 2025 | 2,528 | $1.47M | <0.1% | – | No prior filing | Holders |
| Q2 2025 | – | – | – | – | Not filed | Holders |
| Q1 2025 | 1,195 | $757.9K | <0.1% | −452−27.4% | Reduced | Holders |
| Q4 2024 | 1,647 | $1.17M | <0.1% | +351+27.1% | Added | Holders |
| Q3 2024 | 1,296 | $1.36M | <0.1% | −90−6.5% | Reduced | Holders |
| Q2 2024 | 1,386 | $1.46M | 0.1% | +521+60.2% | Added | Holders |
| Q1 2024 | 865 | $832.6K | <0.1% | +68+8.5% | Added | Holders |
| Q4 2023 | 797 | $700.0K | <0.1% | −153−16.1% | Reduced | Holders |
| Q3 2023 | 950 | $781.9K | 0.1% | −148−13.5% | Reduced | Holders |
| Q2 2023 | 1,098 | $789.0K | 0.1% | +188+20.7% | Added | Holders |
| Q1 2023 | 910 | $747.7K | 0.1% | +240+35.8% | Added | Holders |
| Q4 2022 | 670 | $483.4K | <0.1% | +132+24.5% | Added | Holders |
| Q3 2022 | 538 | $371.0K | <0.1% | +66+14.0% | Added | Holders |
| Q2 2022 | 472 | $279.0K | <0.1% | −5−1.0% | Reduced | Holders |
| Q1 2022 | 477 | $333.0K | <0.1% | +40+9.2% | Added | Holders |
| Q4 2021 | 437 | $276.0K | <0.1% | −13−2.9% | Reduced | Holders |
| Q3 2021 | 450 | $272.0K | <0.1% | +44+10.8% | Added | Holders |
| Q2 2021 | 406 | $227.0K | <0.1% | +406 | New | Holders |